                               SEQUENCE LISTING

<110> THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
 
<120> ALPHA(V)BETA(6) INTEGRIN-BINDING PEPTIDES AND METHODS OF USE 
      THEREOF

<130> 070772-227510PC-1152214

<140> PCT/US2019/050089
<141> 2019-09-06

<150> 62/728,526
<151> 2018-09-07

<160> 121   

<170> PatentIn version 3.5

<210> 1
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 2
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Val Gly Asp Leu Thr Tyr Leu Lys Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 3
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Val Gly Asp Leu Thr Tyr Leu Lys Lys Lys Val Ala Arg Thr 
1               5                   10                  


<210> 4
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 4
Arg Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 5
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 5
Arg Gly Asp Leu Thr Tyr Leu Lys Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 6
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 6
Arg Gly Asp Leu Thr Tyr Leu Lys Lys Lys Val Ala Arg Thr 
1               5                   10                  


<210> 7
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 7
Arg Gly Asp Leu Met Lys Leu Ala Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 8
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 8
Arg Gly Asp Leu Met Lys Leu Ala Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 9
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 9
Arg Gly Asp Leu Met Lys Leu Ala Lys Lys Val Ala Arg Thr 
1               5                   10                  


<210> 10
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 10
Arg Gly Asp Leu Ala Asp Leu Arg Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 11
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 11
Arg Gly Asp Leu Ala Asp Leu Arg Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 12
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 12
Arg Gly Asp Leu Ala Asp Leu Arg Lys Lys Val Ala Arg Thr 
1               5                   10                  


<210> 13
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 13
Arg Gly Asp Leu Arg Glu Leu Ala Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 14
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 14
Arg Gly Asp Leu Arg Glu Leu Ala Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 15
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 15
Arg Gly Asp Leu Arg Glu Leu Ala Lys Lys Val Ala Arg Thr 
1               5                   10                  


<210> 16
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 16
Arg Thr Asp Leu Tyr Lys Leu Gln Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 17
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 17
Arg Thr Asp Leu Tyr Lys Leu Gln Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 18
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 18
Arg Thr Asp Leu Tyr Lys Leu Gln Lys Lys Val Ala Arg Thr 
1               5                   10                  


<210> 19
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 19
Arg Gly Asp Leu Pro Phe Leu Trp Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 20
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 20
Arg Gly Asp Leu Pro Phe Leu Trp Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 21
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 21
Arg Gly Asp Leu Pro Phe Leu Trp Lys Lys Val Ala Arg Thr 
1               5                   10                  


<210> 22
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 22
Arg Ser Asp Leu Thr Pro Leu Phe Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 23
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 23
Arg Ser Asp Leu Thr Pro Leu Phe Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 24
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 24
Arg Ser Asp Leu Thr Pro Leu Phe Lys Lys Val Ala Arg Thr 
1               5                   10                  


<210> 25
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 25
Arg Thr Asp Leu Asp Ser Leu Arg Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 26
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 26
Arg Thr Asp Leu Asp Ser Leu Arg Thr Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 27
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 27
Arg Thr Asp Leu Asp Ser Leu Arg Thr Lys Val Ala Arg Thr 
1               5                   10                  


<210> 28
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 28
Gly Arg Gly Asp Leu Gly Arg Leu Cys Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 29
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 29
Gly Arg Gly Asp Leu Gly Arg Leu Cys Tyr Gln Lys Val Ala Arg Thr 
1               5                   10                  15      


<210> 30
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 30
Gly Arg Gly Asp Leu Gly Arg Leu Cys Tyr Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 31
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 31
Gly Arg Gly Asp Leu Gly Arg Leu Ala Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 32
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 32
Gly Arg Gly Asp Leu Gly Arg Leu Ala Tyr Gln Lys Val Ala Arg Thr 
1               5                   10                  15      


<210> 33
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 33
Gly Arg Gly Asp Leu Gly Arg Leu Ala Tyr Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 34
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 34
Gly Arg Gly Asp Leu Gly Arg Leu Ala Lys Val Ala Arg Thr 
1               5                   10                  


<210> 35
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group

<400> 35
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 36
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group

<400> 36
Arg Gly Asp Leu Ala Asp Leu Arg Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 37
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group

<400> 37
Arg Gly Asp Leu Ala Asp Leu Arg Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 38
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group

<400> 38
Arg Ser Asp Leu Thr Pro Leu Phe Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 39
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Lys(FB)

<400> 39
Val Gly Asp Leu Thr Tyr Leu Lys Lys Lys Val Ala Arg Thr 
1               5                   10                  


<210> 40
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group

<400> 40
Val Gly Asp Leu Thr Tyr Leu Lys Lys Lys Val Ala Arg Thr 
1               5                   10                  


<210> 41
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group

<220>
<223> C-term polyethylene glycol-28

<400> 41
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 42
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group

<220>
<223> C-term polyethylene glycol-28

<400> 42
Arg Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 43
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group - polyethylene glycol-2

<220>
<223> C-term polyethylene glycol-28

<400> 43
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 44
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group - polyethylene glycol-4

<220>
<223> C-term polyethylene glycol-28

<400> 44
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 45
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group - polyethylene glycol-8

<220>
<223> C-term polyethylene glycol-28

<400> 45
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 46
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group - polyethylene glycol-12

<220>
<223> C-term polyethylene glycol-28

<400> 46
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 47
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group - polyethylene glycol-28

<220>
<223> C-term polyethylene glycol-28

<400> 47
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 48
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group - aminomethylbenzoyl group

<220>
<223> C-term polyethylene glycol-28

<400> 48
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 49
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group - polyethylene glycol-28
- aminomethylbenzoyl group

<220>
<223> C-term polyethylene glycol-28

<400> 49
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 50
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group 

<400> 50
Arg Thr Asp Leu Asp Ser Leu Arg Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 51
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group 

<400> 51
Gly Arg Gly Asp Leu Gly Arg Leu Ala Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 52
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 52
Gln Lys Val Ala Arg Thr 
1               5       


<210> 53
<211> 5
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 53
Lys Val Ala Arg Thr 
1               5   


<210> 54
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> C-term fluorobenzoyl group 

<400> 54
Val Gly Asp Leu Thr Tyr Leu Lys Lys 
1               5                   


<210> 55
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> C-term fluorobenzoyl group 

<400> 55
Arg Gly Asp Leu Ala Asp Leu Arg Lys 
1               5                   


<210> 56
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group 

<400> 56
Arg Ser Asp Leu Thr Pro Leu Phe 
1               5               


<210> 57
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group 

<400> 57
Val Gly Asp Leu Thr Tyr Leu Lys Arg Lys Ala Thr Val Gln 
1               5                   10                  


<210> 58
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 58
Asn Ala Val Pro Asn Leu Arg Gly Asp Leu Gln Val Leu Ala Gln Lys 
1               5                   10                  15      


Val Ala Arg Thr 
            20  


<210> 59
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (9)..(9)
<223> Lys([18F]FB)

<400> 59
Val Gly Asp Leu Thr Tyr Leu Lys Lys Lys Val Ala Arg Thr 
1               5                   10                  


<210> 60
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term [18F] fluorobenzoyl group 

<400> 60
Val Gly Asp Leu Thr Tyr Leu Lys Lys Lys Val Ala Arg Thr 
1               5                   10                  


<210> 61
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term [18F] fluorobenzoyl group 

<400> 61
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 62
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term [18F] fluorobenzoyl group 

<400> 62
Val Gly Asp Leu Thr Tyr Leu Lys Arg Lys Ala Thr Val Gln 
1               5                   10                  


<210> 63
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 63
Arg Lys Ala Thr Val Gln 
1               5       


<210> 64
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term [18F] fluorobenzoyl group 

<220>
<223> C-term polyethylene glycol-28

<400> 64
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 65
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term [18F] fluorobenzoyl group 

<220>
<223> C-term polyethylene glycol-28

<400> 65
Arg Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 66
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term [18F] fluorobenzoyl group - polyethylene glycol-2

<220>
<223> C-term polyethylene glycol-28

<400> 66
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 67
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term [18F] fluorobenzoyl group - polyethylene glycol-4

<220>
<223> C-term polyethylene glycol-28

<400> 67
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 68
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term [18F] fluorobenzoyl group - polyethylene glycol-8

<220>
<223> C-term polyethylene glycol-28

<400> 68
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 69
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term [18F] fluorobenzoyl group - polyethylene glycol-12

<220>
<223> C-term polyethylene glycol-28

<400> 69
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 70
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term [18F] fluorobenzoyl group - polyethylene glycol-28

<220>
<223> C-term polyethylene glycol-28

<400> 70
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 71
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term [18F] fluorobenzoyl group - aminomethylbenzoyl
      group

<220>
<223> C-term polyethylene glycol-28

<400> 71
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 72
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term [18F] fluorobenzoyl group - polyethylene glycol-28
- aminomethylbenzoyl group

<220>
<223> C-term polyethylene glycol-28

<400> 72
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 73
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> C-term [18F] fluorobenzoyl group

<400> 73
Val Gly Asp Leu Thr Tyr Leu Lys Lys 
1               5                   


<210> 74
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> C-term [18F] fluorobenzoyl group

<400> 74
Arg Gly Asp Leu Ala Asp Leu Arg Lys 
1               5                   


<210> 75
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term [18F] fluorobenzoyl group

<400> 75
Arg Ser Asp Leu Thr Pro Leu Phe 
1               5               


<210> 76
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term [18F] fluorobenzoyl group

<400> 76
Arg Gly Asp Leu Ala Asp Leu Arg Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 77
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term [18F] fluorobenzoyl group

<400> 77
Arg Ser Asp Leu Thr Pro Leu Phe Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 78
<211> 6
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 78
Lys Gln Val Ala Arg Thr 
1               5       


<210> 79
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group

<400> 79
Arg Thr Asp Leu Asp Ser Leu Arg Thr 
1               5                   


<210> 80
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group

<400> 80
Gly Arg Gly Asp Leu Gly Arg Leu 
1               5               


<210> 81
<211> 20
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group

<400> 81
Asn Ala Val Pro Asn Leu Arg Gly Asp Leu Gln Val Leu Ala Gln Lys 
1               5                   10                  15      


Val Ala Arg Thr 
            20  


<210> 82
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group

<400> 82
Arg Gly Asp Leu Gln Val Leu Ala Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 83
<211> 8
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220>
<223> N-term fluorobenzoyl group

<400> 83
Arg Gly Asp Leu Gln Val Leu Ala 
1               5               


<210> 84
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (9)..(9)
<223> May or may not be present

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 84
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 85
<211> 34
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (19)..(19)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (25)..(25)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (26)..(26)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (27)..(27)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (28)..(28)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (9)..(28)
<223> This region may encompass 0-20 residues

<220>
<221> MISC_FEATURE 
<222> (29)..(29)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 85
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Gln Lys Val Ala 
            20                  25                  30          


Arg Thr 
        


<210> 86
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> E, D, G, A, I, L, M, C, Q, N, V, K, R, H,
      S, T, W, or F 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (9)..(9)
<223> May or may not be present

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 86
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 87
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> G, A, N, I, L, M, C, Q, E, D, K, R, V, H, S,
      T, W, F, or Y 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (9)..(9)
<223> May or may not be present

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 87
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 88
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> V or R

<220>
<221> MOD_RES
<222> (2)..(2)
<223> G, S, or T

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (9)..(9)
<223> May or may not be present

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 88
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 89
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (5)..(5)
<223> T, S, N, Q, M, C, V, L, I, A, G, R, H, K, Y,
      F, E, D, W, or P 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (9)..(9)
<223> May or may not be present

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 89
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 90
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Y, W, K, H, R, D, E, P, G, A, C, M, V, I, L, N,
      Q, S, T, or F 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (9)..(9)
<223> May or may not be present

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 90
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 91
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (5)..(5)
<223> T, M, A, R, Y, P, D, or G

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Y, P, K, D, E, F, S, or R

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (9)..(9)
<223> May or may not be present

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 91
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 92
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (8)..(8)
<223> K, H, A, G, P, I, L, V, R, F, Y, C, S, T, M, Q,
      N, E, D, or W 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (9)..(9)
<223> May or may not be present

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 92
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 93
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> H, R, K, T, or Y 

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 93
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 94
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (8)..(8)
<223> K, A, R, F, Q, C, or W

<220>
<221> MOD_RES
<222> (9)..(9)
<223> K, R, Y, or T

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 94
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 95
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> E, D, G, A, I, L, M, C, Q, N, V, K, R, H, S,
      T, W, or F

<220>
<221> MOD_RES
<222> (2)..(2)
<223> G, A, N, I, L, M, C, Q, E, D, K, R, V, H, S, T,
      W, F, or Y 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> T, S, N, Q, M, C, V, L, I, A, G, R, H, K, Y, F, E,
      D, W, or P 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Y, W, K, H, R, D, E, P, G, A, C, M, V, I, L, N, Q,
      S, T, or F 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> K, H, A, G, P, I, L, V, R, F, Y, C, S, T, M, Q, N,
      E, D, or W 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> H, R, K, T, or Y 

<220>
<221> MISC_FEATURE 
<222> (9)..(9)
<223> May or may not be present 

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 95
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 96
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> G, A, I, L, M, C, V, K, R, or H 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> G, A, N, I, L, Q, E, D, V, S, or T 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> T, S, M, C, V, L, I, A, G, R, K, Y, F, E, D, W, or P 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Y, W, K, R, H, D, E, Q, N, P, S, or F 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> K, A, G, R, F, Y, Q, N, E, D, C, or W 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> R, K, T or Y 

<220>
<221> MISC_FEATURE 
<222> (9)..(9)
<223> May or may not be present 

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 96
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 97
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> V or R 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> G, S, or T 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> T, M, A, R, Y, D, G, or P 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Y, K, D, E, P, S, R, or F 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> K, A, R, F, Q, C, or W 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> K, T, or Y 

<220>
<221> MISC_FEATURE 
<222> (9)..(9)
<223> May or may not be present 

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 97
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 98
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (9)..(9)
<223> May or may not be present 

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 98
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 99
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (9)..(9)
<223> May or may not be present 

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 99
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 100
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> V or R 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> G, T, or S 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> T, A, D, or G 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Y, D, P, S or R 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> K, R, F, or A 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> K, T, or Y 

<220>
<221> MISC_FEATURE 
<222> (9)..(9)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 100
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 101
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> V or R

<220>
<221> MOD_RES
<222> (2)..(2)
<223> G, T, or S 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> T, A, D, or G

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Y, D, P, S or R 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> K, R, F, or A 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> K, T, or Y 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 101
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 102
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> V or R 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> G or S 

<220>
<221> MOD_RES
<222> (5)..(5)
<223> T or A 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Y, D, or P 

<220>
<221> MOD_RES
<222> (8)..(8)
<223> K, R, or F 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 102
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 103
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 103
Arg Gly Asp Leu Ala Asp Leu Arg Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 104
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> V or R 

<220>
<221> MOD_RES
<222> (2)..(2)
<223> G, T, or S

<220>
<221> MOD_RES
<222> (5)..(5)
<223> T, A, D, or G

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Y, D, P, S or R

<220>
<221> MOD_RES
<222> (8)..(8)
<223> K, R, F, or A 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 104
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 105
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> V or R

<220>
<221> MOD_RES
<222> (2)..(2)
<223> G or S

<220>
<221> MOD_RES
<222> (5)..(5)
<223> T or A

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Y, D, or P

<220>
<221> MOD_RES
<222> (8)..(8)
<223> K, R, or F

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 105
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 106
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 106
Val Gly Asp Leu Thr Tyr Leu Lys Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 107
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 107
Arg Gly Asp Leu Ala Asp Leu Arg Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 108
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 108
Arg Ser Asp Leu Thr Pro Leu Phe Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 109
<211> 14
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 109
Arg Thr Asp Leu Asp Ser Leu Arg Gln Lys Val Ala Arg Thr 
1               5                   10                  


<210> 110
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (9)..(9)
<223> May or may not be present 

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 110
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 111
<211> 35
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      polypeptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (10)..(29)
<223> This region may encompass 0-20 residues

<220>
<221> MOD_RES
<222> (11)..(11)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (12)..(12)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (13)..(13)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (14)..(14)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (15)..(15)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (16)..(16)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (17)..(17)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (18)..(18)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (19)..(19)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (20)..(20)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (21)..(21)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (22)..(22)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (23)..(23)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (24)..(24)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (25)..(25)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (26)..(26)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (27)..(27)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (28)..(28)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (29)..(29)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (30)..(30)
<223> May or may not be present

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 111
Gly Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa 
1               5                   10                  15      


Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Xaa Gln Lys Val 
            20                  25                  30          


Ala Arg Thr 
        35  


<210> 112
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220>
<221> MISC_FEATURE 
<222> (11)..(11)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 112
Gly Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15      


<210> 113
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> E, D, G, A, I, L, M, C, Q, N, V, K, R, H, S, T,
      W, or F 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> G, A, N, I, L, M, C, Q, E, D, K, R, V, H, S, T,
      W, F, or Y 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> T, S, N, Q, M, C, V, L, I, A, G, R, H, K, Y, F, E,
      D, W, or P 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Y, W, K, H, R, D, E, P, G, A, C, M, V, I, L, N, Q,
      S, T, or F 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> K, H, A, G, P, I, L, V, R, F, Y, C, S, T, M, Q, N,
      E, D, or W 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> H, R, K, T or Y 

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220>
<221> MISC_FEATURE 
<222> (11)..(11)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 113
Gly Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15      


<210> 114
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> G, A, I, L, M, C, V, K, R, or H 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> G, A, N, I, L, Q, E, D, V, S, or T 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> T, S, M, C, V, L, I, A, G, R, K, Y, F, E, D,
      W, or P 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Y, W, K, R, H, D, E, Q, N, P, S, or F 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> K, A, G, R, F, Y, Q, N, E, D, C, or W 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> R, K, T or Y 

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220>
<221> MISC_FEATURE 
<222> (11)..(11)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 114
Gly Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15      


<210> 115
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> V or R 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> G, S, or T 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> T, M, A, R, Y, D, G, or P 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Y, K, D, E, P, S, R, or F 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> K, A, R, F, Q, C, or W 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> K, T, or Y 

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220>
<221> MISC_FEATURE 
<222> (11)..(11)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 115
Gly Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15      


<210> 116
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> V or R 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> G, T, or S 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> T, A, D, or G 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Y, D, P, S or R 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> K, R, F, or A 

<220>
<221> MOD_RES
<222> (10)..(10)
<223> K, T, or Y 

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 116
Gly Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15      


<210> 117
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> V or R 

<220>
<221> MOD_RES
<222> (3)..(3)
<223> G, T, or S 

<220>
<221> MOD_RES
<222> (6)..(6)
<223> T, A, D, or G 

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Y, D, P, S or R 

<220>
<221> MOD_RES
<222> (9)..(9)
<223> K, R, F, or A 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 117
Gly Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 118
<211> 15
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 118
Gly Arg Gly Asp Leu Gly Arg Leu Ala Gln Lys Val Ala Arg Thr 
1               5                   10                  15  


<210> 119
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220>
<221> MISC_FEATURE 
<222> (11)..(11)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 119
Gly Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa Gln Lys Val Ala Arg Thr 
1               5                   10                  15      


<210> 120
<211> 9
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (1)..(1)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (5)..(5)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (8)..(8)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (9)..(9)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 120
Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa 
1               5                   


<210> 121
<211> 10
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (2)..(2)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (3)..(3)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (6)..(6)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (7)..(7)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (9)..(9)
<223> Any amino acid

<220>
<221> MOD_RES
<222> (10)..(10)
<223> Any amino acid

<220>
<221> MISC_FEATURE 
<222> (10)..(10)
<223> May or may not be present 

<220> 
<223> See specification as filed for detailed description of
      substitutions and preferred embodiments

<400> 121
Gly Xaa Xaa Asp Leu Xaa Xaa Leu Xaa Xaa 
1               5                   10  


